Notably, once a patient transitions to combination injectable therapy, the ADA recommends the addition of a GLP-1 receptor agonist for patients who require improved postprandial glycemic control despite basal insulin optimization
These treatments can be used on various areas of the body, including the double chin, thighs, and abdomen
these patients did not experience any side effects ( Table 1 ), there are currently two other clinical trials in the recruitment phase, which aim to evaluate the effects of A
Yang Z, Tian R, Zhang XJ, Cai J, She ZG, Li H
Market evolution has consistently favored clinical superiority over theoretical convenience, with Lillys displacement of Novo Nordisk exemplifying how efficacy advantages translate to market leadership
Box 66602 Albany, NY 12206-6602 Please allow four to six weeks for processing